THI in full swing about cardiovascular health …. Interesting video presentation….. they are likely a big part of how Mesoblast move forward with our accelerated approval pathway for Rexlemestrocel-L in patients with end-stage ischemic heart failure with reduced ejection fraction (HFrEF) and a left ventricular assist device (LVAD).
https://tv.texasheart.org/cardiolog...md-the-texas-heart-institute-a-year-in-review
THI is committed to excellence in advancing #cardiovascularhealth.
During Grand Rounds, @JRogersMD1, our President & CEO, highlighted achievements in our clinical programs, exciting research accomplishments, and many educational innovations.
Cell Therapy News/Articles, page-17769
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $3.767M | 3.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 25605 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 57632 | 20 |
View Market Depth
| Last trade - 14.32pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |